Eli Lilly (LLY) to Present Ph-3 Ixekizumab Results in Psoriasis Treatment at … – StreetInsider.com
Eli Lilly (LLY) to Present Ph-3 Ixekizumab Results in Psoriasis Treatment at …StreetInsider.comEli Lilly and Company (NYSE: LLY) will showcase results from three pivotal Phase 3 studies investigating ixekizumab for the treatment of moderate-to-severe plaque psoriasis at the 23rd World Congress of Dermatology in Vancouver, British Columbia, June …Lilly to Present Pivotal Phase 3 Study Results for Investigational Psoriasis …PR Newswire (press release)all 4 news articles »
[monetize id=”1″]
[monetize id=”2″]
Psoriasis Free For Life | Cure Psoriasis Fast
Injuries Up Risk of Psoriatic Arthritis for People With Psoriasis – U.S. News & World Report
Injuries Up Risk of Psoriatic Arthritis for People With PsoriasisU.S. News & World ReportFRIDAY, June 12, 2015 (HealthDay News) — Injuries increase the risk of psoriatic arthritis in people who have psoriasis, a new study suggests. Psoriatic arthritis — chronic arthritis associated with the skin condition psoriasis — can lead to severe …and more »
